Slate Path Capital LP
Source: SEC Form 13F · as of Mar 2026Slate Path Capital LP holds 2 biotech & pharma companies tracked by BioSniper, totaling $12.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
2
Total value held
$12.5M
BioSniper AIPage evidence connected
Prepared research question
What matters most for NEWAMSTERDAM PHARMA CO N.V. (NAMS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 319,000 | $10.2M |
| TVRDTvardi Therapeutics, Inc. | 704,118 | $2.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.